The page is the record's research on the issuer — no analyst, no rating, no view. # IMUGENE LIMITED (ASX: IMU) — research page As of 2026-11-06 · au-cm-kg · record version 1 ## Identity and listing IMUGENE LIMITED is listed on the ASX under ticker IMU, ISIN AU000000IMU9, LEI 984500A5C9KF08EAF248. Its security type is Corporate, its sector is Health Care, and its jurisdiction is Australia (ASIC-registered public company). Its segment is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 118 filings in the window 2025-11-06 to 2026-11-06, across 74 filing days. Of these, 65 are ASX announcements, 27 are corporate actions, 8 are director interest notices, 7 are AGM record dates, 4 are quarterly reports, 3 are substantial holder notices, 2 are financial statements, and 2 are halt and resume notices. The median gap between filing days is 4 days. The latest filing is an ASX announcement dated 2026-11-05, one day before the record date. The ASX median cadence gap is 6 days across 1829 issuers, with a median of 58 filings and a median latency of 4.0 days. The Health Care median cadence gap is 5.0 days across 163 issuers, with a median of 65 filings and a median latency of 7 days. ## Auditor The auditor of record is Grant Thornton Audit Pty Ltd. Its location is not on the record. Auditor changes are not on the record, as the market's register has no lifecycle type map yet. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/au/ddo-design-and-distribution-obligations/r1, with the chapter as of 2026-11-04. ## Coverage The record names six research houses on the issuer's investor-relations page: Diamond Equity Research, Research as a Service (RaaS), Bell Potter, Lodge Partners, Bioshares, and Lodge Partners Research. ## Open research The record holds three openly published research notes: Lodge Partners on 2024-09-20, Diamond Equity Research on 2024-08-07, and Diamond Equity Research on 2024-03-14. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record. ## Sources 13 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.asx.com.au/markets/trade-our-cash-market/directory (identity.exchange) - https://www.asx.com.au/markets/company/IMU (identity.isin) - https://data.gov.au/data/dataset/asic-companies (identity.jurisdiction) - https://api.gleif.org/api/v1/lei-records/984500A5C9KF08EAF248 (identity.lei) - https://mcp.au-cm-kg.ai/events/ASX/IMU (the disclosure lines) - https://asx.api.markitdigital.com/asx-research/1.0/markets/announcements ; https://www.nsx.com.au/marketdata/delisted-suspended/ (the halt flag) - https://announcements.asx.com.au/asxpdf/20260828/pdf/073fc64ydb3qfm.pdf (the auditor) - https://mcp.au-cm-kg.ai/book/aio.json (the orderability chapter) - https://imugene.com/investors/analyst-coverage/ (coverage) - https://imugene.com/wp-content/uploads/2024/11/ResearchReport-Initiating-ImugeneLtdIMU-200924.pdf (open research) - https://imugene.com/wp-content/uploads/2024/12/ImugeneAugust2024UpdateNote.pdf (open research) - https://imugene.com/wp-content/uploads/2024/12/ImugeneMarch2024UpdateNote.pdf (open research) - https://mcp.au-cm-kg.ai/record/ASX/IMU (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/au/ASX/IMU · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp